Literature DB >> 19187026

Population-based study of invasive disease due to beta-hemolytic streptococci of groups other than A and B.

Laura N Broyles1, Chris Van Beneden, Bernard Beall, Richard Facklam, P Lynn Shewmaker, Paul Malpiedi, Pamala Daily, Arthur Reingold, Monica M Farley.   

Abstract

BACKGROUND: Beta-hemolytic streptococci of groups other than A and B (NABS) are increasingly recognized as causes of clinically significant disease, but precise information about this heterogeneous group is lacking. We report the incidence of NABS infection and describe the epidemiologic and clinical characteristics.
METHODS: Active, population-based surveillance for invasive NABS was performed over a 2-year period in the 8-county metropolitan Atlanta, Georgia, area and the 3-county San Francisco Bay, California, area. Clinical records were reviewed, and available isolates were sent to the Centers for Disease Control and Prevention (Atlanta) for additional microbiologic characterization. Incidences were calculated using year-appropriate US Census Bureau data.
RESULTS: A total of 489 cases of invasive NABS infection were identified (3.2 cases per 100,000 population). The median age of patients was 55 years; 64% of patients were males, and 87% had underlying diseases. The incidence was higher among black persons than white persons (4.0 vs. 2.5 cases per 100,000 population; P < .01) and increased with age among all races. Infections were community acquired in 416 cases (85%). Among the 450 patients (94%) with NABS infection who were hospitalized, 55 (12%) died. Of 266 isolates (54%) speciated at the Centers for Disease Control and Prevention, 212 (80%) were Streptococcus dysgalactiae subspecies equisimilis; 46 (17%) were members of the Streptococcus anginosus group. S. dysgalactiae subspecies equisimilis primarily presented as skin and soft-tissue infection in older patients, whereas individuals with invasive S. anginosus group infections were more likely to be younger patients with intra-abdominal infections.
CONCLUSIONS: NABS comprise multiple distinct species that cause a significant number of community-acquired invasive infections. Clinical manifestations differ by species. Thus, speciation of invasive NABS may be warranted in clinical settings.

Entities:  

Mesh:

Year:  2009        PMID: 19187026     DOI: 10.1086/597035

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  60 in total

1.  Delineation of Streptococcus dysgalactiae, its subspecies, and its clinical and phylogenetic relationship to Streptococcus pyogenes.

Authors:  Anders Jensen; Mogens Kilian
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

2.  [Perianal streptococcal dermatitis caused by β-hemolytic group G streptococci in two adults].

Authors:  N Scheiba; W Hartschuh
Journal:  Hautarzt       Date:  2011-02       Impact factor: 0.751

Review 3.  Streptococcus dysgalactiae subsp. equisimilis bacteremia: an emerging infection.

Authors:  S Rantala
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-03-29       Impact factor: 3.267

4.  Distribution of emm types in invasive and non-invasive group A and G streptococci.

Authors:  S Vähäkuopus; R Vuento; T Siljander; J Syrjänen; J Vuopio
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-16       Impact factor: 3.267

5.  Inverse association between Lancefield group G Streptococcus colonization and sore throat in slum and nonslum settings in Brazil.

Authors:  Sara Yee Tartof; Frances Farrimond; Juliana Arruda de Matos; Joice Neves Reis; Regina Terse Trindade Ramos; Aurelio Nei Andrade; Mitermayer Galvão dos Reis; Lee Woodland Riley
Journal:  J Clin Microbiol       Date:  2010-11-03       Impact factor: 5.948

6.  Prevalence of a streptococcal inhibitor of a complement-mediated cell lysis-like gene (sicG) in Streptococcus dysgalactiae subsp. equisimilis.

Authors:  Masaaki Minami; Mariko Ichikawa; Hideyuki Matsui; Nanako Hata; Naoki Wakiyama; Masakado Matsumoto; Michio Ohta; Tadao Hasegawa
Journal:  Curr Microbiol       Date:  2010-11-04       Impact factor: 2.188

7.  Sequence diversity of sicG among group C and G Streptococcus dysgalactiae subspecies equisimilis isolates associated with human infections in western Norway.

Authors:  O Oppegaard; H Mylvaganam; S Skrede; N Langeland; B R Kittang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-09-10       Impact factor: 3.267

8.  Molecular characterization and antibiotic resistance of group G streptococci in Israel: comparison of invasive, non-invasive and carriage isolates.

Authors:  T Halperin; H Levine; Z Korenman; S Burstein; R Amber; T Sela; L Valinsky
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-06-21       Impact factor: 3.267

9.  Group G streptococcal sepsis, septic arthritis and myositis in a patient with severe oral ulcerations.

Authors:  Wu Deng; Laurie Farricielli
Journal:  BMJ Case Rep       Date:  2014-01-27

10.  Population genetics of Streptococcus dysgalactiae subspecies equisimilis reveals widely dispersed clones and extensive recombination.

Authors:  David J McMillan; Debra E Bessen; Marcos Pinho; Candace Ford; Gerod S Hall; José Melo-Cristino; Mário Ramirez
Journal:  PLoS One       Date:  2010-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.